Cargando…

Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells

OBJECTIVE: To study the effects of natalizumab treatment on subgroups of circulating peripheral blood B cell populations. METHODS: We studied the proportions and absolute numbers of CD19(+)CD20(+), CD10(+), and CD5(+) B cell populations, and determined very late activation antigen-4 and chemokine re...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraste, Maija, Penttilä, Tarja-Leena, Airas, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079379/
https://www.ncbi.nlm.nih.gov/pubmed/27800533
http://dx.doi.org/10.1212/NXI.0000000000000292